Palladin mutation causes familial pancreatic cancer: Absence in European families [7]

PLoS Medicine

Volumn 4, Issue 4, 2007, Pages 774-

  Slater, Emily ^a   Amrillaeva, Vera ^a   Fendrich, Volker ^a   Bartsch, Detlef ^a   Earl, Julie ^b   Vitone, Louis J ^b   Neoptolemos, John P ^b   Greenhalf, William ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b European Registries of Familial Pancreatic Cancer (EUROPAC)   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; PALLADIN; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; PALLADIN PROTEIN, HUMAN; PHOSPHOPROTEIN;

AGE DISTRIBUTION; CANCER REGISTRY; DIABETES MELLITUS; EUROPE; FAMILIAL CANCER; FAMILY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; INCIDENCE; LETTER; PANCREAS CANCER; PHENOTYPE; CAUCASIAN; GENETICS; MUTATION; NOTE; PANCREAS TUMOR; PEDIGREE;

CYTOSKELETAL PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MUTATION; PANCREATIC NEOPLASMS; PEDIGREE; PHOSPHOPROTEINS;

EID: 34247470247     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040164     Document Type: Letter

References (4)

1. Pogue-Geile KL, Chen R, Bronner MP, Crnogorac-Jurcevic T, Moyes KW, et al. (2006) Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med 3: e516. doi:10.1371/journal.pmed. 0030516
2. Eberle MA, Pfutzer R, Pogue-Geile KL, Bronner MP, Crispin D, et al. (2002) A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am J Hum Genet 70: 1044-1048.
3. Earl J, Yan L, Vitone LJ, Risk J, Kemp SJ, et al. (2006) Evaluation of the 4q32-34 locus in European familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev 15: 1948-1955.
4. Lynch HT, Brand RE, Hogg D, Deters CA, Fusaro RM, et al. (2002) Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: The familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 94: 84-96.